{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:29:38Z","timestamp":1792510178331,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12664-024-01646-7","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:02:17Z","timestamp":1723248137000},"page":"1121-1135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma\u2014A systematic review and meta-analysis"],"prefix":"10.1007","volume":"43","author":[{"given":"Suprabhat","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Strubchevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraprasad","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan Kumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Kozyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5126-1655","authenticated-orcid":false,"given":"Akash","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,10]]},"reference":[{"key":"1646_CR1","doi-asserted-by":"crossref","unstructured":"Trinchet JC, Bourcier V, Chaffaut C, et al. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort). Hepatology. 2015;62:737\u201350.","DOI":"10.1002\/hep.27743"},{"key":"1646_CR2","doi-asserted-by":"crossref","unstructured":"Reig M, Forner A, Rimola J,\u00a0et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76:681\u201393.","DOI":"10.1016\/j.jhep.2021.11.018"},{"key":"1646_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/s-0034-1382794","volume":"31","author":"WE Saad","year":"2014","unstructured":"Saad WE. The history and future of transjugular intrahepatic portosystemic shunt: food for thought. Semin Intervent Radiol. 2014;31:258\u201361.","journal-title":"Semin Intervent Radiol"},{"key":"1646_CR4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R de Franchis","year":"2022","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C. Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022;76:959\u201374.","journal-title":"J Hepatol."},{"key":"1646_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1055\/s-0034-1382790","volume":"31","author":"A Copelan","year":"2014","unstructured":"Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol. 2014;31:235\u201342.","journal-title":"Semin Intervent Radiol"},{"key":"1646_CR6","doi-asserted-by":"crossref","unstructured":"Chen X, Qiu ZK, Wang GB, Chen XL, Zhang FJ, Gao F. Effect of transjugular intrahepatic portosystemic shunt on transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis. Diagn Interv Radiol. 2021;27:671\u20136.","DOI":"10.5152\/dir.2021.20358"},{"key":"1646_CR7","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"1646_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"1646_CR9","doi-asserted-by":"crossref","unstructured":"Dariushnia SR, Haskal ZJ, Midia M, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol. 2016;27:1\u20137.","DOI":"10.1016\/j.jvir.2015.09.018"},{"key":"1646_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"1646_CR11","doi-asserted-by":"crossref","unstructured":"Jiang ZB, Shan H, Shen XY, et al. Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis. World J Gastroenterol. 2004;10:1881\u20134.","DOI":"10.3748\/wjg.v10.i13.1881"},{"key":"1646_CR12","doi-asserted-by":"crossref","unstructured":"Liu L, Zhao Y, Qi X, et al. Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res. 2014;44:621\u201330.","DOI":"10.1111\/hepr.12162"},{"key":"1646_CR13","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3748\/wjg.v20.i6.1602","volume":"20","author":"JB Zhao","year":"2014","unstructured":"Zhao JB, Feng C, Zhu QH, He XF, Li YH, Chen Y. Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol. 2014;20:1602\u20137.","journal-title":"World J Gastroenterol"},{"key":"1646_CR14","doi-asserted-by":"crossref","unstructured":"Bettinger D, Kn\u00fcppel E, Euringer W, et al. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma. Aliment Pharmacol Ther. 2015;41:126\u201336.","DOI":"10.1111\/apt.12994"},{"key":"1646_CR15","doi-asserted-by":"crossref","unstructured":"Qiu B, Zhao MF, Yue ZD, et al. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. World J Gastroenterol. 2015;21:12439\u201347.","DOI":"10.3748\/wjg.v21.i43.12439"},{"key":"1646_CR16","doi-asserted-by":"crossref","unstructured":"Yao J, Zuo L, An G, et al. Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma and portal hypertension. J Gastrointestin Liver Dis. 2015;24:301\u20137.","DOI":"10.15403\/jgld.2014.1121.243.yao"},{"key":"1646_CR17","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s00270-017-1655-8","volume":"40","author":"B Qiu","year":"2017","unstructured":"Qiu B, Li K, Dong X, Liu FQ. Transjugular intrahepatic portosystemic shunt for portal hypertension in hepatocellular carcinoma with portal vein tumor thrombus. Cardiovasc Intervent Radiol. 2017;40:1372\u201382.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1646_CR18","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.12998\/wjcc.v7.i13.1599","volume":"7","author":"SH Luo","year":"2019","unstructured":"Luo SH, Chu JG, Huang H, Yao KC. Safety and efficacy of transjugular intrahepatic portosystemic shunt combined with palliative treatment in patients with hepatocellular carcinoma. World J Clin Cases. 2019;7:1599\u2013610.","journal-title":"World J Clin Cases"},{"key":"1646_CR19","doi-asserted-by":"publisher","first-page":"100864","DOI":"10.1016\/j.tranon.2020.100864","volume":"13","author":"H Yan","year":"2020","unstructured":"Yan H, Wang G, Zhu W, et al. Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites. Transl Oncol. 2020;13:100864.","journal-title":"Transl Oncol"},{"key":"1646_CR20","doi-asserted-by":"crossref","unstructured":"Dong H, Zhang C, Li Z, et al. Trans-jugular intrahepatic portosystemic shunt in patients with hepatic cellular carcinoma: a preliminary study. J Cancer Res Ther. 2021;17:784\u20139.","DOI":"10.4103\/jcrt.jcrt_467_21"},{"key":"1646_CR21","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1007\/s00261-021-03214-5","volume":"46","author":"HL Lu","year":"2021","unstructured":"Lu HL, Xuan FF, Luo YC, Qin X. Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization\/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt. Abdom Radiol (NY). 2021;46:5417\u201327.","journal-title":"Abdom Radiol (NY)"},{"key":"1646_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/MEG.0000000000001750","volume":"33","author":"J Luo","year":"2021","unstructured":"Luo J, Li M, Wu C, et al. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy for prevention of variceal rebleeding in patients with hepatocellular carcinoma meeting the Milan criteria. Eur J Gastroenterol Hepatol. 2021;33:436\u201342.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1646_CR23","doi-asserted-by":"crossref","unstructured":"Tsauo J, Tie J, Xue H, et al. Transjugular intrahepatic portosystemic shunt creation for the prevention of gastric variceal rebleeding in patients with hepatocellular carcinoma: a multicenter retrospective study. J Vasc Interv Radiol. 2021;32:963\u20139.","DOI":"10.1016\/j.jvir.2021.04.005"},{"key":"1646_CR24","doi-asserted-by":"publisher","first-page":"e934436","DOI":"10.12659\/MSM.934436","volume":"27","author":"X Zou","year":"2021","unstructured":"Zou X, Xue M, Li J. Combined use of transjugular intrahepatic portosystemic shunt and transarterial chemoembolization in the treatment of esophageal and gastric variceal bleeding: a retrospective study of 80 patients with hepatocellular carcinoma and portal hypertension. Med Sci Monit. 2021;27:e934436.","journal-title":"Med Sci Monit"},{"key":"1646_CR25","doi-asserted-by":"crossref","unstructured":"Chen Y, Ma X, Zhang X,\u00a0et al. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus \u03b2-blocker. Hepatol Int. 2022;16:1379\u201389.","DOI":"10.1007\/s12072-022-10388-7"},{"key":"1646_CR26","first-page":"1838","volume":"14","author":"H Han","year":"2022","unstructured":"Han H, Meng Y, Wang J. Effect of transjugular intrahepatic portosystemic shunt combined with 125I particle implantation on portal vein tumor thrombus in hepatocellular carcinoma. Am J Transl Res. 2022;14:1838\u201348.","journal-title":"Am J Transl Res"},{"key":"1646_CR27","doi-asserted-by":"crossref","unstructured":"Qiu Z, Wang G, Yan H,\u00a0et al. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension. Eur Radiol. 2022;32:6777\u201387.","DOI":"10.1007\/s00330-022-08705-7"},{"key":"1646_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40644-022-00451-9","volume":"22","author":"H Yan","year":"2022","unstructured":"Yan H, Qiu Z, Xiang Z, Feng K, Huang M, Gao F. TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience. Cancer Imaging. 2022;22:13.","journal-title":"Cancer Imaging"},{"key":"1646_CR29","doi-asserted-by":"crossref","unstructured":"Zhang X, Tsauo J, Tie J,\u00a0et al. Emergent transjugular intrahepatic portosystemic shunt creation for acute gastric variceal bleeding in patients with hepatocellular carcinoma. J Vasc Interv Radiol. 2022;33:702\u20136.","DOI":"10.1016\/j.jvir.2022.03.012"},{"key":"1646_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jhep.2022.11.019","volume":"78","author":"D Thabut","year":"2023","unstructured":"Thabut D, Kudo M. Treatment of portal hypertension in patients with HCC in the era of Baveno VII. J Hepatol. 2023;78:658\u201362.","journal-title":"J Hepatol"},{"key":"1646_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12876-023-03047-0","volume":"23","author":"A Fichtl","year":"2023","unstructured":"Fichtl A, Seufferlein T, Zizer E. Risks and benefits of TIPS in HCC and other liver malignancies: a literature review. BMC Gastroenterol. 2023;23:403.","journal-title":"BMC Gastroenterol"},{"key":"1646_CR32","first-page":"623","volume":"16","author":"PC Huang","year":"2021","unstructured":"Huang PC, Zhao M, Wei YY, Xia FF, Li H. Transjugular intrahepatic portosystemic shunt: a meta-analysis of 8 mm versus 10 mm stents. Wideochir Inne Tech Maloinwazyjne. 2021;16:623\u201332.","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"key":"1646_CR33","doi-asserted-by":"crossref","unstructured":"Bai M, Qi X, Yang Z,\u00a0et al. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol. 2011;26:943\u201351.","DOI":"10.1111\/j.1440-1746.2011.06663.x"},{"key":"1646_CR34","doi-asserted-by":"crossref","unstructured":"Giri S, Kale A, Shukla A. Efficacy and safety of transjugular intrahepatic portosystemic shunt creation for Budd-Chiari syndrome: a systematic review and meta-analysis. J Vasc Interv Radiol. 2022;33:1301\u201312.e13.","DOI":"10.1016\/j.jvir.2022.07.022"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-024-01646-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-024-01646-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-024-01646-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T11:03:21Z","timestamp":1730631801000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-024-01646-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,10]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1646"],"URL":"https:\/\/doi.org\/10.1007\/s12664-024-01646-7","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,10]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SG, AS, SD, KS, TT, RKP, MK and AR declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable for systematic review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for the results\/findings and content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}